who offers tirzepatide Something New. Something More Effective. We're excited to now offer as part of our medically supervised weight loss program. Why this matters: ✓ Targets both GLP-1 & GIP pathways ✓ Supports Zepbound Vials Online | Zepbound

In addition to the original R1 formulation of 3, 7 and 14mg, there is now a more conservative R2 dosing formulation of 1.5, 4 and 9mg

Over a 12-week period, the participants were randomized to receive dulaglutide 1.5 mg, placebo, or once-weekly subcutaneous injections of LY3437943

The research suggests substantial weight reductions at all three doses, positioning Tirzepatide as a significant advancement in the medical management of obesity

In 2024, semaglutide 2.4 mg (Wegovy) received FDA approval for reducing cardiovascular risk in adults with established cardiovascular disease and either obesity or overweight with at least one weight-related comorbidity, based on the SELECT trial

For acne, lower-dose isotretinoin may be appropriate for patients who: Are highly sensitive to side effects Require prolonged treatment Have difficulty tolerating standard doses For GLP-1 medications, lower dosing within approved ranges may be reasonable if a patient is responding well